HEALTHPEAK PROPERTIES INC
For the period ended Mar 31, 2025. Filed Apr 25, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 25, 2025
DOC$20.26+0.7%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share and per share data)
| March 31,2025 | December 31,2024 | |
|---|---|---|
| ASSETS | ||
| Real estate: | ||
| Buildings and improvements | $16,176,176 | $16,115,283 |
| Development costs and construction in progress | 962,714 | 880,393 |
| Land and improvements | 2,941,082 | 2,918,758 |
| Accumulated depreciation and amortization | (4,240,220) | (4,083,030) |
| Net real estate | 15,839,752 | 15,831,404 |
| Loans receivable, net of reserves of $7,554 and $10,499 | 698,525 | 717,190 |
| Investments in and advances to unconsolidated joint ventures | 951,978 | 936,814 |
| Accounts receivable, net of allowance of $2,040 and $2,243 | 68,908 | 76,810 |
| Cash and cash equivalents | 70,625 | 119,818 |
| Restricted cash | 67,981 | 64,487 |
| Intangible assets, net | 747,789 | 817,254 |
| Assets held for sale, net | 7,840 | 7,840 |
| Right-of-use asset, net | 422,017 | 424,173 |
| Other assets, net | 940,314 | 942,465 |
| Total assets | $19,815,729 | $19,938,255 |
| LIABILITIES AND EQUITY | ||
| Bank line of credit and commercial paper | $164,000 | $150,000 |
| Term loans | 1,646,335 | 1,646,043 |
| Senior unsecured notes | 6,714,279 | 6,563,256 |
| Mortgage debt | 352,051 | 356,750 |
| Intangible liabilities, net | 179,002 | 191,884 |
| Lease liability | 306,577 | 307,220 |
| Accounts payable, accrued liabilities, and other liabilities | 670,221 | 725,342 |
| Deferred revenue | 939,855 | 940,136 |
| Total liabilities | 10,972,320 | 10,880,631 |
| Commitments and contingencies (Note 11) | ||
| Redeemable noncontrolling interests | 14,417 | 2,610 |
| Common stock, $1.00 par value: 1,500,000,000 shares authorized; 698,611,840 and 699,485,139 shares issued and outstanding | 698,612 | 699,485 |
| Additional paid-in capital | 12,827,628 | 12,847,252 |
| Cumulative dividends in excess of earnings | (5,345,120) | (5,174,279) |
| Accumulated other comprehensive income (loss) | 6,927 | 28,818 |
| Total stockholders’ equity | 8,188,047 | 8,401,276 |
| Joint venture partners | 299,923 | 315,821 |
| Non-managing member unitholders | 341,022 | 337,917 |
| Total noncontrolling interests | 640,945 | 653,738 |
| Total equity | 8,828,992 | 9,055,014 |
| Total liabilities and equity | $19,815,729 | $19,938,255 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.